- Home
- Publications
- Publication Search
- Publication Details
Title
Tocilizumab for treating juvenile idiopathic arthritis
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 16, Issue 4, Pages 559-566
Publisher
Informa Healthcare
Online
2016-02-06
DOI
10.1517/14712598.2016.1150997
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
- (2015) Shumpei Yokota et al. ANNALS OF THE RHEUMATIC DISEASES
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
- (2015) Christoph Garbers et al. CURRENT OPINION IN IMMUNOLOGY
- Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
- (2015) S. Yokota et al. JOURNAL OF RHEUMATOLOGY
- Uveitis associated with juvenile idiopathic arthritis
- (2015) Ethan S. Sen et al. Nature Reviews Rheumatology
- Radiological improvement by tocilizumab in polyarticular juvenile idiopathic arthritis
- (2015) Yusuke Tozawa et al. PEDIATRICS INTERNATIONAL
- Tocilizumab for severe refractory neuro-Behçet: Three cases IL-6 blockade in neuro-Behçet
- (2015) Olga Addimanda et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Inhibition of Natural Killer Cell Cytotoxicity by Interleukin-6: Implications for the Pathogenesis of Macrophage Activation Syndrome
- (2015) Loredana Cifaldi et al. Arthritis & Rheumatology
- Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial
- (2015) Fabrizio De Benedetti et al. Arthritis & Rheumatology
- FRI0328 Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): 2-year data from tender, a phase 3 clinical trial
- (2014) F. De Benedetti et al. ANNALS OF THE RHEUMATIC DISEASES
- The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
- (2014) Jaime Guzman et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
- (2014) Hermine I Brunner et al. ANNALS OF THE RHEUMATIC DISEASES
- Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register
- (2014) Marieke H Otten et al. ANNALS OF THE RHEUMATIC DISEASES
- Macrophage activation syndrome and cytokine-directed therapies
- (2014) Grant S. Schulert et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Interleukin-6 and its receptors: A highly regulated and dynamic system
- (2014) Janina Wolf et al. CYTOKINE
- Clinically Inactive Disease in a Cohort of Children with New-onset Polyarticular Juvenile Idiopathic Arthritis Treated with Early Aggressive Therapy: Time to Achievement, Total Duration, and Predictors
- (2014) C. A. Wallace et al. JOURNAL OF RHEUMATOLOGY
- Discrepancy Between Clinical and Radiological Responses to Tocilizumab Treatment in Patients with Systemic-onset Juvenile Idiopathic Arthritis
- (2014) C. Aoki et al. JOURNAL OF RHEUMATOLOGY
- Extension Study of Participants from the Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis
- (2014) C. A. Wallace et al. JOURNAL OF RHEUMATOLOGY
- Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan
- (2014) S. Yokota et al. JOURNAL OF RHEUMATOLOGY
- Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study
- (2014) M. Araki et al. NEUROLOGY
- Subcutaneous Tocilizumab Versus Placebo in Combination With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis
- (2014) Alan Kivitz et al. ARTHRITIS CARE & RESEARCH
- A6: Tapering and Withdrawal of Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis in Inactive Disease: Results From an Alternative Dosing Regimen in the TENDER Study
- (2014) Fabrizio De Benedetti et al. Arthritis & Rheumatology
- A1: Clinical Inactive Disease in the Pediatric Rheumatology Care and Outcomes Improvement Network Cohort: Which Components of Clinical Inactive Disease Do Patients Not Achieve?
- (2014) Catherine A. Bingham et al. Arthritis & Rheumatology
- The Biology and Medical Implications of Interleukin-6
- (2014) T. Tanaka et al. Cancer Immunology Research
- Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
- (2013) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009
- (2013) L. R. Harrold et al. JOURNAL OF RHEUMATOLOGY
- Advances from clinical trials in juvenile idiopathic arthritis
- (2013) Daniel J. Lovell et al. Nature Reviews Rheumatology
- Tocilizumab for Severe Chronic Anterior Uveitis Associated with Juvenile Idiopathic Arthritis in a Pediatric Patient
- (2013) Adrian C. Tsang et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis
- (2013) Xiaoping Zhang et al. Expert Review of Clinical Pharmacology
- Tocilizumab for the Treatment of Juvenile Idiopathic Arthritis
- (2012) Kendra Decelle et al. ANNALS OF PHARMACOTHERAPY
- Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
- (2012) Maxime Dougados et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic juvenile idiopathic arthritis
- (2012) Alberto Martini AUTOIMMUNITY REVIEWS
- Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The diagnostic significance of interleukin-18 and interleukin-6
- (2012) Masaki Shimizu et al. CYTOKINE
- Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis
- (2012) Yutaka Inaba et al. Modern Rheumatology
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A comparative proteomic study of sera in paediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS–A pilot study
- (2012) Anita Rana et al. Pediatric Rheumatology
- Successful Tocilizumab Treatment in a Child With Refractory Takayasu Arteritis
- (2012) B. Bravo Mancheno et al. PEDIATRICS
- Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment
- (2011) Y. Inaba et al. ANNALS OF THE RHEUMATIC DISEASES
- Therapeutic Targeting of the Interleukin-6 Receptor
- (2011) Toshio Tanaka et al. Annual Review of Pharmacology and Toxicology
- Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: Implication for the pathogenesis of macrophage activation syndrome
- (2011) Raffaele Strippoli et al. ARTHRITIS AND RHEUMATISM
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Transporter-Mediated Drug–Drug Interactions
- (2011) L Zhang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
- (2011) Toshio Tanaka et al. FEBS LETTERS
- Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
- (2011) Tomoyuki Imagawa et al. Modern Rheumatology
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- The pattern of response to anti–interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
- (2008) Marco Gattorno et al. ARTHRITIS AND RHEUMATISM
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
- (2008) N. Nishimoto et al. BLOOD
- Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production
- (2008) Yasushi Uchiyama et al. INTERNATIONAL IMMUNOPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started